MyChesCo on MSN27d
Pathways Neuro Pharma Targets Rare Pediatric Neurological Disorders with Pioneering Gene Therapy
Looking Ahead Pathways Neuro Pharma’s bold strategic shift and cutting-edge gene therapy platform mark a turning point in ...
Baylor College of Medicine4y
Neurology & Developmental Neuroscience Residency Rotations and Pathways
Training in Neurodevelopmental Disabilities is described after the comparative table. PGY 1 (Intern Year in Pediatrics followed by residents in all tracks): General Outpatient Pediatrics – clinics in ...
Baylor College of Medicine4y
Neurology & Developmental Neuroscience Residency Programs
There are three pathways by which a resident can receive training in the Pediatric Neurosciences, with differences related to specific individual interests. All three pathways begin in year one of ...
Mena FN1mon
Pathways Neuro Pharma Inc. Announces Strategic Focus On Rare Pediatric Diseases, Led By Juvenile Parkinson's Disease
(MENAFN- EIN Presswire) Pathways Neuro Pharma shifts focus to rare pediatric diseases, advancing a groundbreaking non-agonist gene therapy for Juvenile Parkinson's Disease. Children diagnosed with ...
EurekAlert!6d
Researchers link exosomes to blood-brain barrier dysfunction in pediatric obstructive sleep apnea
A new study by researchers from Marshall University and the University of Missouri highlights how exosomes—tiny vesicles released by cells—may play a key role in blood-brain barrier (BBB) dysfunction ...